Tumors affecting the optic nerves and visual pathways
Pituitary Tumors & Visual Pathway Compression in Los Angeles
Vision loss from a pituitary tumor or other brain tumor pressing on the visual pathways can develop gradually — sometimes so slowly that you don't notice until significant damage has occurred. A neuro-ophthalmologist plays a critical role in detecting, monitoring, and coordinating treatment for tumors that threaten your vision.
What is Pituitary Tumors & Visual Pathway Compression?
Pituitary adenomas are the most common tumors that affect the visual pathways. As they grow upward from the pituitary gland, they can compress the optic chiasm — the crossing point of the optic nerves — causing a characteristic pattern of vision loss called bitemporal hemianopia (loss of peripheral vision on both sides). Other tumors that can compress the visual pathways include meningiomas (of the sphenoid wing, tuberculum sellae, or optic nerve sheath), craniopharyngiomas, and gliomas. Early detection through visual field testing is critical, as vision loss from compression is often reversible if the tumor is treated before permanent optic nerve damage occurs.
Symptoms of Pituitary Tumors & Visual Pathway Compression
- Gradual loss of peripheral vision — often unnoticed until advanced
- Difficulty with side vision — bumping into things, missing objects to the side
- Bitemporal hemianopia — loss of outer visual fields in both eyes
- Decreased visual acuity if the optic nerve is directly compressed
- Headaches
- Hormonal symptoms (irregular periods, decreased libido, galactorrhea, growth changes)
- Double vision from cavernous sinus involvement
- Pale optic disc (optic atrophy) on exam
Common Causes of Pituitary Tumors & Visual Pathway Compression
- Pituitary adenoma — the most common cause of chiasmal compression
- Meningioma (tuberculum sellae, sphenoid wing, optic nerve sheath)
- Craniopharyngioma
- Optic nerve glioma
- Metastatic tumors
- Rathke cleft cyst
- Aneurysms compressing the visual pathways
- Inflammatory conditions (sarcoidosis, IgG4-related disease)
How We Evaluate Pituitary Tumors & Visual Pathway Compression
Evaluation includes detailed visual field testing (Humphrey perimetry) to detect and characterize the pattern of vision loss, OCT of the retinal nerve fiber layer to assess for optic nerve damage, and visual acuity and color vision testing. MRI of the brain with dedicated pituitary protocol and gadolinium contrast is the imaging study of choice. Hormonal testing (prolactin, growth hormone, cortisol, thyroid function) is performed when a pituitary adenoma is suspected. Serial visual fields are used to monitor for progression or improvement after treatment.
Treatment Options
Treatment depends on the tumor type, size, and degree of visual compromise. Prolactinomas often respond to medical therapy (cabergoline) alone, shrinking without surgery. Other pituitary adenomas, meningiomas, and craniopharyngiomas typically require neurosurgical removal if they are causing vision loss. The neuro-ophthalmologist plays a central role before, during, and after treatment — documenting baseline visual function, helping determine surgical urgency, and monitoring visual recovery postoperatively.
- Neurosurgical removal (transsphenoidal surgery for pituitary adenomas)
- Medical therapy (cabergoline for prolactinomas — may shrink the tumor without surgery)
- Radiation therapy (stereotactic radiosurgery) for residual or recurrent tumors
- Observation with serial visual field monitoring for small, non-compressive tumors
- Hormone replacement therapy for pituitary insufficiency
- Neuro-ophthalmic monitoring of visual field recovery after treatment
Why Choose Dr. Ghiam for Pituitary Tumors & Visual Pathway Compression
- Expert visual field interpretation to detect subtle compression patterns
- Close collaboration with neurosurgery to guide surgical timing and urgency
- Pre- and post-operative visual monitoring to track recovery
- Experience with complex cases involving multiple visual pathway tumors
- Ability to distinguish tumor-related vision loss from other causes
The neuro-ophthalmologist is often the first to detect visual pathway compression through visual field testing — sometimes before the patient even notices symptoms. We quantify the degree of visual loss, help determine surgical urgency, and monitor recovery after treatment. Our expertise in interpreting subtle visual field changes is critical for optimal timing of intervention.
Get Expert Help for Pituitary Tumors & Visual Pathway Compression
If you have a known pituitary tumor or are experiencing gradual vision changes, neuro-ophthalmic evaluation can detect problems early and guide treatment decisions. Contact our Los Angeles office.